With diabetes and other diseases at epidemic levels, the need for more pharmacies to step up and offer accessible, convenient patient screening for a variety of serious and even life-threatening conditions is clear, a panel of pharmacists asserted at the NACDS Total Store Expo “Convenient Care — Point of Care Testing in the Pharmacy” Insight Session in late August. So, too, is the opportunity to drive new business to the pharmacy through point-of-care testing services.
Roche on Tuesday announced that the Accu-Chek Aviva Expert system is now available by prescription.
More than 75 locally-owned community pharmacies throughout Arkansas are enhancing patient care by participating in a unique nine-month medication adherence program.
Roundy’s stores on Monday announced that flu shots were made available at all pharmacies.
Community pharmacists can dramatically help their patients stick to their prescription regimens, according to a new study led by researchers at the University of Pittsburgh School of Pharmacy.
Thanks to the Centers for Medicare and Medicaid Services’ Five-Star Quality Rating System, the diabetes community stands to play a significant role in how pharmacies think about their patients and their medication adherence programs.
Managing such chronic conditions as diabetes has become a core competency among many retail pharmacies. It dovetails well with the retail pharmacy industry’s goal to become a destination center for patients proactively seeking to improve their health and wellness.
Sales of the popular Type 2 diabetes drug metformin may get a boost if physicians begin prescribing the medicine as a prophylactic in people who don’t have diabetes. A recent study published in the diabetes journal Diabetes, Obesity and Metabolism and conducted by scientists from Cardiff University found that patients treated with metformin could live longer than people without diabetes.
While Google and Alcon figure out the next wireless 007-style eyewear to help manage diabetes, there are device manufacturers today who are developing next-generation blood-glucose meters.
Dick Tracy has nothing on the wearable gadgets under development to help people better police their diabetes. Wearable technologies in its totality — which include Google Glass and the Apple Watch — are part of a booming market that’s expected to swell to $20 billion by 2015 and is further expected to grow at a compound annual growth rate of nearly 40% over the next six years.